The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2017 | The circle of CLL
Carlo Croce, MD from Ohio State University, Columbus, OH provides an interesting overview of chronic lymphocytic leukemia (CLL) at the International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2017 held in New York, NY. Prof. Croce provides an insight into the discovery of the genetic mechanism and targets of CLL. He explains in detail the advances in CLL in terms of drug therapies which have been able to target the BCL2 gene, a gene he discovered, which has revolutionized treatment for CLL patients.
